First-pass extracted concept

ophthalmic optogenetics

Candidate: concept label1 source documents3 linked claims

Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Evidence Snippets

Here, we review the more recent promising optogenetic molecules, vectors, and applications of optogenetics for the treatment of retinal degeneration and glaucoma.

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1review2022BiomoleculesDOI PubMed

1 evidence snippet 3 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1research use summarysupports2022Source 1DOI PubMed

Optogenetic strategies can serve as translational research tools to study retinal degeneration pathogenesis and identify clinically relevant therapeutic targets.

Claim 2review scope summarysupports2022Source 1DOI PubMed

Ophthalmic optogenetics is being explored in pre-clinical and phase I/II clinical settings as a potential treatment approach for major blinding eye diseases including glaucoma and retinitis pigmentosa.

Claim 3translational advantagesupports2022Source 1DOI PubMed

Optogenetic visual restoration strategies are attractive because they are agnostic to the genetic causes of retinal degeneration, potentially broadening treatability across retinal dystrophic and degenerative diseases.